Mantle Cell Lymphoma Consortium (MCLC) News

Below you will find the latest information to come out of the Lymphoma Research Foundation's (LRF) Mantle Cell Lymphoma Consortium.

MCL Highlights from ASCO

MCL abstracts selected from the May/June 2009 ASCO meeting.

LRF's 2009 MCL Scientific Workshop

A summary of presentations from LRF's annual MCL Workshop.

Lenalidomide produces high response rate

Lenalidomide is well-tolerated and active in relapsed/refractory MCL patients.

What has the Mantle Cell Lymphoma Consortium been up to?

Update from Dr. Michael Williams (Mantle Cell Lymphoma Consortium Chairman)

Current State of MCL

Interview with Dr. Michael Williams (Mantle Cell Lymphoma Consortium Chairman)

Clinical Trial Update

MCL abstracts selected from the December 2008 ASH meeting.

Mantle Cell Lymphoma: 30 Years of Progress

Investigators claim a two-fold increase in overall survival in advanced stage MCL.

2008 Mantle Cell Lymphoma Workshop

View highlights of the MCL Workshop Spring 2008 or order a copy of the Workshop report.

2008 ASCO Annual Meeting

View MCL highlights from the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting.

New Executive Committee Members

Get to know the newest members to join the MCLC Executive Committee.

Mantle Cell Lymphoma Cell Bank is Now Available

The Lymphoma Research Foundation (LRF), in collaboration with American Type Culture Collection (ATCC), has recently created a Mantle Cell Lymphoma (MCL) Cell Bank.  The Cell Bank is a collection of various MCL lines created by scientists from all over the world.  The idea for the Cell Bank was generated by the scientists that make up the MCL Consortium (MCLC).  It was created to provide a single, centralized location where scientists can easily acquire high-quality, well-characterized MCL cell lines in an effort to accelerate discoveries in MCL.